Abstract A248: integrated therapeutic antibody development at the National Research Council of Canada

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1158/1535-7163.TARG-13-A248
AuthorSearch for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1
Name affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
Abstract
Publication date
PublisherAmerican Association for Cancer Research
In
LanguageEnglish
Peer reviewedYes
NPARC number23001783
Export citationExport as RIS
Report a correctionReport a correction
Record identifier48620866-e604-46da-927c-8af3a64ad827
Record created2017-04-06
Record modified2020-04-22
Date modified: